Credit Suisse Ag Haemonetics Corp Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Haemonetics Corp stock. As of the latest transaction made, Credit Suisse Ag holds 88,271 shares of HAE stock, worth $5.24 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

88,271

Previous 86,996 1.47%

Holding current value

$5.24 Million

Previous $7.44 Million 1.26%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$71.24 - $85.35 $90,831 - $108,821	1,275 Added 1.47%	88,271 $7.53 Million
Q4 2023 Feb 08, 2024	BUY	$80.59 - $92.61 $527,945 - $606,688	6,551 Added 8.14%	86,996 $7.44 Million
Q3 2023 Nov 13, 2023	SELL	$82.56 - $93.49 $6,439 - $7,292	-78 Reduced 0.1%	80,445 $7.21 Million
Q2 2023 Aug 11, 2023	BUY	$80.84 - $89.45 $693,849 - $767,749	8,583 Added 11.93%	80,523 $6.86 Million
Q1 2023 May 10, 2023	BUY	$72.75 - $90.6 $216,140 - $269,172	2,971 Added 4.31%	71,940 $5.95 Million
Q4 2022 Feb 13, 2023	BUY	$73.85 - $86.14 $1.03 Million - $1.2 Million	13,952 Added 25.36%	68,969 $5.42 Million
Q3 2022 Nov 10, 2022	BUY	$63.3 - $78.66 $309,473 - $384,568	4,889 Added 9.75%	55,017 $4.07 Million
Q2 2022 Aug 12, 2022	SELL	$49.27 - $66.08 $101,200 - $135,728	-2,054 Reduced 3.94%	50,128 $3.27 Million
Q1 2022 May 16, 2022	BUY	$43.77 - $63.22 $145,403 - $210,016	3,322 Added 6.8%	52,182 $3.3 Million
Q4 2021 Feb 14, 2022	SELL	$49.55 - $74.59 $571,113 - $859,724	-11,526 Reduced 19.09%	48,860 $2.59 Million
Q3 2021 Nov 12, 2021	SELL	$57.6 - $70.59 $953,395 - $1.17 Million	-16,552 Reduced 21.51%	60,386 $4.26 Million
Q2 2021 Aug 16, 2021	BUY	$51.81 - $118.56 $896,520 - $2.05 Million	17,304 Added 29.02%	76,938 $5.13 Million
Q1 2021 May 14, 2021	SELL	$111.01 - $139.48 $15.8 Million - $19.8 Million	-142,118 Reduced 70.44%	59,634 $6.62 Million
Q4 2020 Feb 12, 2021	BUY	$88.75 - $119.95 $4.83 Million - $6.52 Million	54,389 Added 36.91%	201,752 $24 Million
Q3 2020 Nov 13, 2020	BUY	$75.65 - $93.58 $4.75 Million - $5.88 Million	62,849 Added 74.37%	147,363 $12.9 Million
Q2 2020 Aug 12, 2020	SELL	$84.96 - $118.91 $20.3 Million - $28.5 Million	-239,386 Reduced 73.91%	84,514 $7.57 Million
Q1 2020 May 13, 2020	BUY	$74.34 - $121.82 $12.5 Million - $20.4 Million	167,626 Added 107.26%	323,900 $32.3 Million
Q4 2019 Feb 12, 2020	BUY	$114.37 - $129.46 $11.5 Million - $13 Million	100,695 Added 181.17%	156,274 $18 Million
Q3 2019 Nov 12, 2019	SELL	$117.16 - $138.52 $1.05 Million - $1.24 Million	-8,925 Reduced 13.84%	55,579 $7.01 Million
Q2 2019 Aug 14, 2019	SELL	$81.74 - $120.34 $2.68 Million - $3.95 Million	-32,823 Reduced 33.72%	64,504 $7.76 Million
Q1 2019 May 14, 2019	BUY	$83.25 - $102.12 $998,833 - $1.23 Million	11,998 Added 14.06%	97,327 $8.52 Million
Q4 2018 Feb 13, 2019	SELL	$90.66 - $116.63 $3.09 Million - $3.97 Million	-34,041 Reduced 28.52%	85,329 $8.54 Million
Q3 2018 Nov 13, 2018	SELL	$89.96 - $114.58 $544,797 - $693,896	-6,056 Reduced 4.83%	119,370 $13.7 Million
Q2 2018 Aug 14, 2018	BUY	$71.53 - $95.75 $1.94 Million - $2.6 Million	27,151 Added 27.63%	125,426 $11.2 Million
Q1 2018 May 15, 2018	BUY	$60.72 - $74.41 $531,967 - $651,906	8,761 Added 9.79%	98,275 $7.19 Million
Q4 2017 Feb 14, 2018	SELL	$44.96 - $58.99 $908,416 - $1.19 Million	-20,205 Reduced 18.42%	89,514 $5.2 Million
Q3 2017 Nov 14, 2017	BUY	$40.38 - $44.87 $1.39 Million - $1.54 Million	34,308 Added 45.49%	109,719 $4.92 Million
Q2 2017 Aug 14, 2017	BUY	N/A	75,411	75,411 $2.98 Million

Others Institutions Holding HAE

# of Institutions

337

Shares Held

54.3M

Call Options Held

689K

Put Options Held

345K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.05B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account